NCT00564447View on ClinicalTrials.gov

Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2007

Conditions
Bacterial InfectionsEye Infections
Interventions
DRUG

Azithromycin

azithromycin topical solution 1% given as a single drop in a single eye

DRUG

Moxifloxacin

Moxifloxacin topical solution given as a single drop in a single eye

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00564447 - Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers | Biotech Hunter | Biotech Hunter